Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Buckner

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Medicinal Chemistry|November 7, 2016
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ximena Barros-Álvarez, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Biochimie|December 15, 2010
Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphateEric T Larson, Jessica E Kim, Frank H Zucker, et al.
Biochimie|April 22, 2017
Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterpartsXimena Barros-Álvarez, Keshia M Kerchner, Cho Yeow Koh, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2020
Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, WashingtonFrederick S Buckner, Denise J McCulloch, Vidya Atluri, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2005
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Oliver Hucke, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Medicinal Chemistry|November 7, 2016
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ximena Barros-Álvarez, et al.
Journal of Medicinal Chemistry|January 9, 2004
Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agentsJunko Ohkanda, Frederick S Buckner, Jeffrey W Lockman, et al.
Biochimie|December 15, 2010
Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphateEric T Larson, Jessica E Kim, Frank H Zucker, et al.
Biochimie|April 22, 2017
Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterpartsXimena Barros-Álvarez, Keshia M Kerchner, Cho Yeow Koh, et al.
Journal of Molecular Biology|March 23, 2011
The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimerEric T Larson, Jessica E Kim, Lisa J Castaneda, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2020
Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, WashingtonFrederick S Buckner, Denise J McCulloch, Vidya Atluri, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2005
Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasitesMatthew P Glenn, Sung-Youn Chang, Oliver Hucke, et al.
Pageof 12